The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization

Rui Jia1, Qinghua Pan, Shilei Ding

  • 1Key Laboratory of Molecular Microbiology and Biotechnology (Ministry of Education) and Key Laboratory of Microbial Functional Genomics (Tianjin), College of Life Sciences, Nankai University, Tianjin, China.

Journal of Virology
|October 12, 2012
PubMed

Insights

Interferon-inducible transmembrane protein 3 (IFITM3) variants affect viral restriction. A specific IFITM3 variant lacking N-terminal amino acids impairs influenza A virus inhibition by altering protein localization, but not HIV-1 inhibition.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Interferon-inducible transmembrane (IFITM) proteins restrict enveloped virus infections.
  • A specific IFITM3 allele, lacking the N-terminal 21 amino acids, is associated with severe flu outcomes and fails to inhibit influenza A virus.
  • Viral entry mechanisms, including pH-dependent and independent pathways, influence susceptibility to IFITM-mediated restriction.

Purpose of the Study:

  • To investigate the functional role of the N-terminal 21 amino acids of IFITM3 in viral restriction.
  • To determine how the deletion of the N-terminal region affects IFITM3 localization and its ability to inhibit different viruses.
  • To elucidate the mechanism by which IFITM3 restricts pH-dependent and pH-independent viral entry.

Main Methods:

  • Site-directed mutagenesis to create an IFITM3 mutant lacking the N-terminal 21 amino acids.
  • Confocal microscopy to assess the subcellular localization of wild-type and mutant IFITM3.
  • Viral infection assays using influenza A virus and HIV-1 to evaluate antiviral activity.

Main Results:

  • Deletion of the N-terminal 21 amino acids of IFITM3 caused its relocation from endosomal compartments to the cell periphery.
  • The N-terminal deletion mutant lost the ability to inhibit influenza A virus, which enters cells via low pH-dependent endosomes.
  • Both wild-type IFITM3 and the N-terminal deletion mutant exhibited equal efficacy in inhibiting HIV-1 replication, which enters cells via a pH-independent route.

Conclusions:

  • The N-terminal region of IFITM3 is specifically required for restricting viruses that utilize pH-dependent entry pathways, such as influenza A virus.
  • IFITM3 can inhibit viruses employing diverse entry mechanisms, with its N-terminal domain playing a critical role in targeting specific routes.
  • Understanding IFITM3's differential activity based on viral entry mechanisms provides insights into host antiviral defense strategies.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...